Sero-prevalence and risk factors for maternal and umbilical cord hepatitis B surface antigenaemia at delivery in a South-West Nigerian State

尼日利亚西南部某州分娩时母婴乙型肝炎表面抗原血症的血清流行率及危险因素

阅读:1

Abstract

INTRODUCTION: hepatitis B is a global public health issue affecting about 2 billion people, with 350 million chronic carriers. There is growing pressure to test pregnant women for hepatitis B in Nigeria, as studies show high rates of the virus in both mothers and children. Objectives: this cross-sectional study aimed at determining the sero-prevalence of hepatitis B surface antigen among pregnant women and their newborns and identifying risk factors associated with hepatitis B surface antigen positivity among pregnant women receiving care in tertiary hospitals in Ekiti State, Southwest Nigeria. METHODS: two hundred women were recruited into the study from Federal Teaching Hospital, Ido-Ekiti, and Ekiti State University Teaching Hospital, Ado-Ekiti between 1(st) May 2022 and 31(st) October 2022. The presence of risk factors for hepatitis B infection was sought in the mothers. Maternal venous blood and umbilical cord blood were analyzed for the presence of hepatitis B surface antigen. Data analysis was carried out using a statistical program for social sciences (SPSS) version 28 (SPSS Inc., Chicago, Illinois, USA). RESULTS: the mean age of the women was 30.43 years (SD 4.524). Thirty-three (16.5%) of the women studied were into hospital-related professions while 6 (3%) were hairdressers. Sixteen (16) of the 200 women tested positive for HBsAg giving a maternal sero-prevalence of 8% while only 1 of the 200 babies tested positive for HBsAg with a neonatal sero-prevalence of 0.5%. The vertical transmission was 6.25%. CONCLUSION: high endemicity of hepatitis B virus infection in pregnancy was demonstrated in the study. It has, therefore, become imperative to strengthen the structure of the various preventive arms of hepatitis B infection in pregnancy such as advocacy on increased community awareness and handling of risk factors, widespread vaccination campaigns, and routine testing during prenatal care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。